Form 4 · Filed Jun 9, 2026, 11:42 PM UTC
LGND/LIGAND PHARMACEUTICALS INC
Zimmermann Martine — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | A | other | 836 | $0 | $0 | 5,279 |
| Jun 5, 2026 | F | other | 182 | $237 | $43,134 | 5,097 |
| Jun 5, 2026 | A | other | 2,938 | — | — | 2,938 |
Source: SEC EDGAR raw filing ↗ · Accession 0002001011-26-000101